Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Puma Biotechnology, Inc. (PBYI) had Income from Continuous Operations of $13.44M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$75.45M |
|
$13.44M |
|
$23.13M |
|
$52.33M |
|
$58.35M |
|
$17.11M |
|
$0.00M |
|
$17.11M |
|
$17.11M |
|
$13.44M |
|
|
Income from Continuous Operations |
$13.44M |
$13.44M |
|
$13.44M |
|
$17.11M |
|
$19.76M |
|
50.01M |
|
50.65M |
|
$0.26 |
|
$0.26 |
|
| Balance Sheet Financials | |
$162.69M |
|
$0.19M |
|
$53.62M |
|
$216.30M |
|
$81.25M |
|
-- |
|
$4.71M |
|
$85.96M |
|
$130.34M |
|
$88.95M |
|
$130.34M |
|
50.41M |
|
| Cash Flow Statement Financials | |
$41.80M |
|
$-36.19M |
|
$-45.20M |
|
$71.31M |
|
$31.73M |
|
$-39.58M |
|
$6.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.00 |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
69.35% |
|
22.67% |
|
22.67% |
|
-- |
|
22.67% |
|
17.81% |
|
$41.73M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
4.19 |
|
1.41 |
|
64.00 |
|
10.31% |
|
15.11% |
|
6.21% |
|
10.31% |
|
$2.59 |
|
$0.82 |
|
$0.83 |
|